稀释每股收益(EPS)同比接近翻倍!药明康德用真金白银的持续回购注销诠释了什么是股东利益最大化

证券市场周刊
29 Apr

4月28日,药明康德(603259.SH/2359.HK)公布的一季报显示,2025年第一季度,公司营业收入达到96.5亿元,同比增长21%;归母净利润达36.72亿元,同比增长89.1%;经调整non-IFRS归母净利润为26.78亿元,同比增长40%;扣非归母净利润为23.29亿元,同比增长14.5%。相较于营收和利润增长更强劲的是股东收益。受持续回购注销股份的影响,2025年第一季度,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10